RC-VALO Publish and promote clinical research

Direct Epidemio-Statistics helps medical specialists, research organizations, pharmaceutical companies, and public health agencies promote their clinical research in high-impact English journals through its expert assistance in epidemiostatistics.

RC-AVP / Addictions (psychiatrie)
RISK-SCO / Accident de la route
CIR / Agrément 2022, 23, 24
exchanging data to carry out the epidemio statistics of a high impact clinical research study.png

What does our consulting service involve?

Assisting you from data reception to publication

Our expertise in epidemiostatistics helps you elucidate the distribution and determinants of population health events that you study.

We support you from receiving your clinical study data to publishing the results in scientific journals.

horizontal line

Plan the Analysis

To precisely address your research project, we aim to have a clear understanding of your questions, objectives, and the data used.

Planning epidemiostatistical analysis can involve:

exchanging about the conception of your clinical study design.png
  • Reviewing the study protocol to align the analysis with your objectives
  • Identifying methods, sample size, power, and hypotheses
  • Planning the execution timeline, resources, and optional analyses
  • Checking assumptions, outliers, missing data, or correlation
  • Defining the treatment of missing data
  • Specifying the model, variables, transformations, or interactions

Manage and Cleanse Data

Once the data is collected, we clean and prepare it for analysis, which involves checking for missing or incorrect data, correcting errors, and ensuring that the data is in a suitable format for analysis.

The phase of data management and cleansing may include:

data table with missing values to be imputed or filtered out in clinical epidemiology.png
  • Detecting input errors, coding errors, or other issues
  • Handling missing data through imputation or exclusion of cases
  • Correcting errors to determine correct or plausible values
  • Recoding variables by transforming, merging, or stratifying
  • Creating derived variables by combining existing variables
  • Checking data consistency before analysis

Perform Descriptive Analysis

Next, we describe the data with the aim of summarizing the characteristics of the study population and the measured results.

This step involves producing graphs and tables to visualize the data. For this purpose, we will, in particular:

scatter plot statistical average with epidemio statistics for clinical epidemiology 2.png
  • Calculate central tendencies (mean, median, and mode)
  • Calculate dispersions (min-max, quantiles, standard deviation, and variance)
  • Create visualizations (histograms, box plots, scatter plots, etc.)
  • Check for outliers and consider their potential impact
  • Check for missing data that can affect accuracy and reliability
  • Check assumptions of distribution (normality, homoscedasticity)
  • Explore relationships between variables (correlations or associations)

Conduct Inferential Analysis

The next step involves conducting statistical inference, testing hypotheses, estimating relationships between variables, or making predictions about future events.

Our intervention may include:

gaussian curve of epidemio statistics consulting for clinical epidemiology.png
  • Select appropriate statistical tests (t-test, ANOVA, chi-square, regression)
  • Verify test assumptions to ensure result reliability
  • Calculate the test statistic and p-value (can the statistic be due to chance?)
  • Consider the sample size that influences statistical power
  • Adjust p-values in case of multiple tests due to increased risk of false positives
  • Interpret the results in the context of the research question and hypotheses

Interpret the Results

Next, we interpret the results in the light of the research questions addressed and the limitations of the analysis. We contribute to the discussion on the implications of the results, the advancement of the research field, and the formulation of recommendations.

To properly interpret the results, we assist you in:

heatmap with a dendogram from epidemio statistics consulting for clinical epidemiology.png
  • Examine the test results (statistic, p-value, intervals, effects)
  • Determine significance - can these results be attributed to chance?
  • Interpret effect size (relative risk, odds ratio)
  • Establish the study's limitations (assumptions, biases, sample size)
  • Understand the potential impact on patient care
  • Extend the results considering the research question and existing literature

Write the Results and Publish

The final step typically involves writing the analysis results in the form of a manuscript for publication. We assist in organizing the results in a logical structure, writing clear and concise descriptions of methods and results, and formatting the manuscript according to the target journal's guidelines.

We assist you in:

clinical study design driving to scientific results.png
  • Order and prioritize the results
  • Summarize the statistical significance and importance of the results
  • Define symbols, number, and caption tables and figures
  • Report the study's limitations (working assumptions, biases, sample size)
  • Position these results in the context of your research question
  • Conclude on the main findings and implications of the study
horizontal line

What are our prices? How to contact us?

Contact us today for an initial appointment or a personalized quote

get in touch with us.png

Contact Form

horizontal line

Answers to questions you may have

Frequently Asked Questions

— What is the expertise and experience of Direct Epidemio-Statistics in epidemiology and statistics?

The team members have a strong academic background, with advanced degrees in machine learning and postdoctoral experience in epidemiostatistics. The team members have published in leading journals. The company is also certified CIR by the Ministry of National Education and Research (2022-23-24). This combination of education, training, and professional experience provides the team with a high level of expertise in designing clinical studies and epidemiostatistics to improve the design of these studies.

— Will the mission be executed quickly? What will be the timelines?

Completing projects for our clients within deadlines is important to Direct Epidemio-Statistics. To answer the question of availability, we can provide an overview of our current workload and work with you to discuss the timeline for your project. If needed, we are flexible on the scope of the project. The project can also be done in stages. We aim to communicate openly and transparently. We will keep you informed of any delays or potential issues that may arise.

— What are the fees?

The price of Direct Epidemio-Statistics services varies based on several factors, including whether it is a one-time consultation or an ongoing contract, the budget of the clinical research project, and the nature of the client. For example, a one-time consultation is generally more expensive than a consultation as part of a longer collaboration with multiple consultations because a longer collaboration involves time and resources that can span a longer period, while a one-time consultation requires more intensive and targeted effort, resulting in a higher one-time cost. Additionally, the price is affected by whether or not the consultants are involved in disseminating the results in scientific journals and the visibility it brings.
Rates depend heavily on the time spent on publication. For example, for a SIGAPS-A or -B, several weeks to months of work are required. However, for a SIGAPS-E or NC, the epidemiostatistics can be expedited in a few days to hours.

— Can references from previous clients be provided?

The team members at Direct Epidemio-Statistics have diverse backgrounds and areas of expertise. Some of this expertise was developed prior to clients coming to the company, while other expertise has been developed at Direct Epidemio-Statistics. Regarding references, we do not make all of them public. However, for a selection of our clients, we list their names and testimonials on our website or on social media. If you are interested in specific references or would like to speak with one of our former clients, please feel free to contact us, and we will do our best to fulfill your request.

— How will the analysis ensure objectivity and impartiality?

Objectivity and impartial analysis are essential for the long-term credibility of Direct Epidemio-Statistics. To ensure that our analysis meets these standards, we use established methods and review the data and results with you. We can also involve multiple analysts or independent reviewers to further guarantee objectivity and impartial results. If necessary, we can also sign a conflict of interest statement to further demonstrate our commitment to objectivity and impartial analysis.

— How will communication and collaboration be handled during the project?

Direct Epidemio-Statistics regularly communicates with you through your preferred method, whether it is via email, phone, or video conference. We establish a step-by-step schedule and provide regular updates on progress. To ensure the project is conducted efficiently, we encourage open and transparent communication.

— What measures will be taken to protect the confidentiality of data and research?

To ensure the confidentiality of clients' data and research, Direct Epidemio-Statistics only accepts anonymized data, which means that Direct Epidemio-Statistics does not have personally identifiable information (PII); therefore, the risk of patient confidentiality breach is very low. Additionally, the computer systems of Direct Epidemio-Statistics have hard drives that encrypt data at rest, providing an additional layer of security for your data. Finally, the team is aware of the importance of confidentiality and the potential threats that exist.

— How does billing work in the context of a public hospital?

Direct Epidemio-Statistics understands that billing processes can be complex, especially for young physician-researchers working in public hospitals. Your public hospital most certainly uses CHORUS, the national state portal that simplifies and speeds up the payment process for providers by public administrations—and thus, your hospital. To invoice you, we need the Principal Investigator (PI) to be authorized to sign a quote (if applicable, add someone with that authority such as a department head). And then, simply indicate the target service to which to direct the digital invoice. In terms of VAT, the amount is generally not relevant to the spending and budget decision as hospitals are also VAT collectors (all or part of the VAT will be offset).

— What are the deliverables?

The deliverables are an analysis report (PDF) in English, ranging from 10 to 50 pages (indicative), with a methods section, a list of the main findings, and paragraphs, tables, and graphs to write the article. Argumentative and editorial contributions to articles, as well as responses to reviewers at the methodological and statistical level, are also part of the deliverables.

— What are the timelines?

The timeline for carrying out the epidemiostatistical analysis is estimated and specified in the quote as a time interval. This timeline mainly depends on the targeted impact factor, but also on our familiarity with the subject matter and our workload plan. In general, the mission starts at the signing of the order and ends at the latest on the date of publication in a scientific journal.

— What are the prerequisites for the mission?

The mission requires anonymized, raw, untreated, and unimputed data, including data throughout the lifecycle (create, update, delete), co-authorship of articles in position 3 (from the beginning or end), and being a statistical and manuscript contributor to the articles.

Need information? Want to publish?
Get in touch to organize a live exchange.